Abnova and Ardic Instruments Collaborate on Fiber-Optic Protein Quantification System

Abnova Corporation (Taipei City, Taiwan), a biotech company specializing in high throughput monoclonal antibody production, and Ardic Instruments (Taipei City, Taiwan), provider of analytical instruments for nanotechnology, unveiled their new label-free protein detection platform. Based on a new fiber-optic particle, plasmon resonance (FO-PPR) system, this new protein platform enables the development of a variety of applications ranging from protein quantification to protein-protein/protein-small molecule interactions to kinetic measurements.

Most significantly, the FO-PPR technology meets an unmet need for higher sensitivity, protein quantification using a stand-alone, capturing antibody in contrast to the conventional platform currently used, which requires both capturing and detection antibody for protein detection. The Abnova and Ardic collaboration harnesses their expertise in reagent manufacturing and instrument engineering providing an integrated solution for label-free protein-quantification markets.

“We are very excited to have the opportunity to collaborate with Ardic to introduce an unprecedented label-free system for the biotech industry,” said Dr. Wilber Huang, president and CEO of Abnova.

“As an instrument developer, we are eager to work with an antibody reagent manufacturer like Abnova,” stated Dr. Jerome Shen, president and CEO of Ardic Instruments. “Being a pioneer in this new field of FO-PPR, we are keen to have the largest possible applications available to the customers to capture a greater market share in today’s competitive landscape.”

Related Links:
Abnova
Ardic Instruments